Past seminars » Department of Pharmacotherapy and Translational Research » College of Pharmacy

Fall 2019 – Spring 2020

May 29 – Yimei Huang, PharmD, Graduate Student, Department of Pharmacotherapy and Translational Research: “The Role of Metabolic Syndrome and Sodium-Glucose Co-Transporter 2 Inhibitors in Heart Failure”
May 22 – Alan Duvall, PharmD, PGY-2 Ambulatory Care Pharmacy Resident, Department of Pharmacotherapy and Translational Research: “Implementation of chronic obstructive pulmonary disease (COPD) care bundles in a rural family medicine clinic to prevent acute COPD exacerbation related hospital admissions”
May 19 – D. Garrett Smith, PharmD, PGY-1 Community Pharmacy Resident, Department of Pharmacotherapy and Translational Research: “Answering the Call: the role of community pharmacy residency programs in preparing pharmacists for independent pharmacy ownership”
May 15 – Angelina Vascimini, PharmD, PGY-1 Community Pharmacy Resident, Department of Pharmacotherapy and Translational Research: “Leading change to better patient care, Reduction in the Co-prescribing of Opioids and Benzodiazepines”
May 12 – Jeremy Sparks, PharmD, PGY-2 Ambulatory Care Pharmacy Resident, Department of Pharmacotherapy and Translational Research: “Assessing use of advanced monitoring technologies for people with diabetes in a rural-based family medicine clinic”
May 8 – Amanda Elchynski, PharmD, Postdoctoral Fellow in Clinical Pharmacogenomics, Department of Pharmacotherapy and Translational Research: “Determining the Potential Value of Panel-Based Pharmacogenetic Testing in Patients with Chronic Pain and Gastroesophageal Reflux Disease”
May 5 – Tiffany Iwamura, PharmD, PGY-1 Pharmacy Resident, Department of Pharmacotherapy and Translational Research: “An Analysis of the Implementation of Automatic Call System Technology to Increase Efficiency While Maintaining Patient Safety and Quality”
May 1 – Rachel Shaddock, PharmD, PGY-1 Pharmacy Resident, Department of Pharmacotherapy and Translational Research: “Effects of 24-hour Blood Pressure Monitoring in an Interdisciplinary Hypertension Clinic”
April 17 – Christopher R. Piszczatoski, PharmD, Postdoctoral Fellow in Family Medicine, Department of Pharmacotherapy and Translational Research: “Two-Year Results from a Collaborative High-Risk Diabetes Management Clinic in Family Medicine”
April 10 – Lakshmi Manasa S Chekka, PhD candidate and Graduate Assistant, Department of Pharmacotherapy and Translational Research: “High-throughput OpenArray microRNA expression profiling – Discovery of microRNA biomarkers of antihypertensive response to thiazides”
April 3 – Karla Claudio, PhD, Postdoctoral Fellow in Genomic Medicine, Department of Pharmacotherapy and Translational Research: “Psychiatry: a view from the perspective of precision medicine”
March 27 – Mohammad Gbadamosi, Graduate Research Assistant, Department of Pharmacotherapy and Translational Research: “A seven-gene gene expression score predicts outcome in patients treated with gemtuzumab ozogamicin”
February 24 – Janel Long-Byle, PharmD, PhD, Associate Professor, Department of Clinical Pharmacy, University of California San Francisco: “Improving Outcomes in Pediatric Bone Marrow Transplant With The Application of Model-Based Dosing”
February 19 – Erica Woodahl, PhD, Associate Professor, School of Public and Community Health Sciences, University of Montana: “Precision Medicine Under the Big Sky: Implementation in Rural and Underserved Settings”
January 31 – Margie Snyder, PharmD, MPH, Associate Professor of Pharmacy Practice, College of Pharmacy, Purdue University: “Establishing a Practice-based Research Network of Community Pharmacies: Experiences and Lessons Learned”
January 24 – Rachel Dalton, PharmD, MS, Postdoctoral Fellow, Department of Pharmacotherapy and Translational Research: “Current Prescribing and Future Potential of Drugs with Pharmacogenetic Associations in Patients with Geographic and Socioeconomic Barriers to Health Care Access”
December 6 – Jorge Duconge-Soler, PhD, Professor, Department of Pharmaceutical Sciences, School of Pharmacy, University of Puerto Rico: “PGX studies in Caribbean Hispanics: A 10-year path toward adopting a Precision Medicine paradigm in Puerto Rico”
November 22 – Surakit Nathisuwan, PharmD, Associate Professor, Department of Pharmacy, Mahidol University, Bangkok, Thailand: “Impact of the US-Thai Pharmacy School Consortium on the Advancement of Pharmacy in Thailand”
November 15 – Abdelrahman H. Elsayed, MSc, Graduate Research Assistant, Department of Pharmacotherapy and Translational Research: “Penalized LASSO Regression Defines Leukemic Stem Cell (LSC) and Drug Response Scores of Prognostic Significance in AML”
November 8 – Joe Collins, PhD, Postdoctoral Researcher, Department of Pharmacotherapy and Translational Research: “Cis & Trans Regulation at the CYP3As”
November 1 – Eunjeong (Elena) Shin, Graduate Student, Department of Pharmacotherapy and Translational Research: “Time-kill curve analysis for in vitro evaluation of antimicrobials against Klebsiella pneumoniae”
October 25 – Leanne Dumeny, MSM, Graduate Student, Department of Pharmacotherapy and Translational Research & UF Genetics Institute: “Aldosterone: a Key Pathologic Mechanism of Heart Failure with Preserved Ejection Fraction”
October 16 – Wayne L. Russell, RPh, PharmD, FASHP, Associate Vice President of Pharmacy – Premier, Inc.: “Impact of Drug Shortages on Patients and Providers and Efforts to Mitigate this decades old problem”
October 11 – Lea Eiland, PharmD., Associate Department Head & Clinical Professor, Pharmacy Practice Department, Auburn University: “A Multifaceted Scholarship Approach”
September 20 – Mohammad H. Alshaer, Pharm.D., Graduate Assistant, Department of Pharmacotherapy and Translational Research: “Therapeutic Optimization of Beta-lactams: A PK/PD Approach”
September 13 – Kenneth Royal, Ph.D., MSEd, Associate Professor, North Carolina State University: “Criterion-Referenced Exams and Interpretation”
September 6 – Yuli Qian, M.S., Graduate Student, Department of Pharmacotherapy and Translational Research: “Inhibition of Carboxylesterase 1 by Cannabinoids and Implications for Heroin Metabolism”
August 30 – Roya Rafiee, BSN, M.Sc., Ph.D., Postdoctoral Research Associate, Department of Pharmacotherapy and Translational Research: “Genome-Scale CRISPR-Cas9 Synthetic Lethal Screening of Myeloid Cell Line Identified Functional Modulators of Etoposide Resistance Predictive of Clinical of Clinical Outcomes in AML Patients”
August 23 – Nasim Vahabi, Ph.D, Postdoctoral Fellow, Department of Pharmacotherapy and Translational Research: “Integration of Multi-omic Data Using Machine Learning”

Fall 2018 – Spring 2019

May 31 – Mohammed Gbadamosi, Graduate Research Assistant, Department of Pharmacotherapy & Translational Research, University of Florida: “Novel Approaches to Improving CD33-Directed Immunotherapy”
May 24 – Karla Claudio, Postdoctoral Fellow in Genomic Medicine, Department of Pharmacotherapy & Translational Research, University of Florida: “An insight to Tourette syndrome & chronic tics: history, onset, lifetime prevalence, pathophysiology and genetics”
May 17 – Lakshmi Manasa S. Chekka, PharmD, Graduate Student, Department of Pharmacotherapy & Translational Research, University of Florida: “Hydrochlorothiazide Versus Chlorthalidone- Debate For The Best Thiazide Continues” (Presentation begins at 32:40 mark)
May 17 – Leanne Dumeny, Graduate Student, Department of Pharmacotherapy & Translational Research, University of Florida: “Genetic-Discrimination Interaction as a Determinant of Blood Pressure Variation in the Jackson Heart Study”
May 10 – Elise M.L. Carpenter, PharmD, PGY2 Ambulatory Care Pharmacy Resident, Department of Pharmacotherapy & Translational Research, University of Florida: “Identifying Osteoporosis Care Opportunities for Pharmacists in a Rural Clinic Setting”
May 3 – Brent Lovato, PharmD, PGY1 Ambulatory Care Pharmacy Resident, Department of Pharmacotherapy & Translational Research, University of Florida: “Management of Uncontrolled Hypertension: Ambulatory Blood Pressure Monitoring and Subsequent Therapy Modification or Shifting Anti-hypertensive Medication to Night-time Dosing”
April 26 – Cameron D. Thomas, PharmD, Postdoctoral Fellow in Genomic Medicine, Department of Pharmacotherapy & Translational Research, University of Florida: “A PAINful Pharmacogenomic Implementation: CYP2D6 Genotyping in Patients Undergoing Total Joint Arthoplasty”
April 19 – Thakul Rattanasuwan, PharmD, Internal Medicine Pharmacy Fellow, Department of Pharmacotherapy & Translational Research, University of Florida: “Spontaneous Bacterial Peritonitis: Impact of an Albumin Order Set” (Presentation begins at 20:00 mark)
April 19 – Christelle Lteif, PharmD, Graduate Student, Department of Pharmacotherapy & Translational Research, University of Florida: “Beta-blocker Dose Stratifies Both Mortality Risk and Circulating Procollagen Levels in a Predominantly African American Heart Failure Population”
April 12 – Dana Crawford, PhD, Associate Professor, Departments of Population and Quantitative Health Sciences and Genetics and Genome Sciences, Cleveland Institute for Computational Biology: “Challenges in Precision Medicine Research: The Cleveland Experience”
April 5 – Divita Singh, PharmD, PGY2 Ambulatory Care Pharmacy Resident, Department of Pharmacotherapy & Translational Research, University of Florida: “Evaluating the Effects of In-Clinic Patient Conducted Blood Pressure Measurements on Workflow in a Rural Clinic”
April 5 – Kelsey Melloy, PharmD, PGY2 Clinical Pharmacogenomics Resident, Department of Pharmacotherapy & Translational Research, University of Florida: “Patient Attitudes and Beliefs about Pharmacogenetic Consult Clinic in a Primary Care Setting”
March 29 – Scott G. Garland, PharmD, Postdoctoral Fellow, Departments of Pharmacotherapy & Translational Research and Community Health & Pharmacy, University of Florida: “Evaluation of a Type 2 Diabetes Mellitus Pharmacist-Physician Collaborative Clinic on Diabetes Care Measures and Overall Disease Management in At-Risk Populations”
March 22 – Philip E. Empey, PharmD, PhD, Assistant Professor, Pharmacy and Therapeutics, University of Pittsburgh: “Advancing Genomics Implementation through High Fidelity Education: The Test2lean Model”
March 1 – Wael Alghamdi, PharmD, Graduate Student, Department of Pharmacotherapy & Translational Research, University of Florida: “Pharmacokinetics of Efavirenz in HIV and TB/HIV Pediatric Patients” (Presentation begins at 30:00 mark)
March 1 – Mohammad H. Alshaer, PharmD, BCPS, Graduate Student, Department of Pharmacotherapy & Translational Research, University of Florida: “Optimal use of fluoroquinolones in MDR TB”
February 22 – Ailey Pestcoe, PharmD, PGY-1 Resident MTM/Geriatrics, Center for Quality Medication Management, University of Florida: “Analyzing the success rates of resolving medication therapy problems (MTPs) utilizing telephonic and non-telephonic interventions at the Center for Quality Medication Management (CQM) at the University of Florida in a Medicaid population”
February 22 – Desiree Morales, PharmD, PGY-1 Resident MTM/Geriatrics, Center for Quality Medication Management, University of Florida: “Comparing productivity rates and quality of Medication Therapy Management (MTM) services between clinical staff pharmacists and clinical contract pharmacists at the Center for Quality Medication Management (CQM) at the University of Florida” (Presentation begins at 20:00 mark)
January 25 – Sonal Singh, PhD, Postdoctoral Fellow, Department of Pharmacotherapy & Translational Research, University of Florida: “Genome Wide Meta-Analysis of Blood Pressure (BP) Response to β-Blockers (βB): Results from International Consortium of Antihypertensive Pharmacogenomics Studies (ICAPS)”
December 7 – Craig Lee, PharmD, PhD, Associate Professor, Division of Pharmacotherapy and Experimental Therapeutics, University of North Carolina: “Clinical Outcomes of CYP2C19 Genotype-Guided Escalation and De-escalation of Antiplatelet Therapy after PCI”
November 30 – Wael Alghamdi, PharmD, Graduate Student, Department of Pharmacotherapy & Translational Research, University of Florida: “Treatment Outcomes in Tuberculosis from Three Centers in the US”
November 16 – Lilian Azzopardi, BPharm (Hons), MPhil, PhD, Professor of Pharmacy, University of Malta: “Clinical Pharmacy Practice, Education and Research in Malta”
November 9 – Jeffrey Cain, EdD, MS, Associate Professor, Department of Pharmacy Practice & Science, University of Kentucky: “Are smartphones driving us crazy? What the research is indicating”
October 26 – Nihal El Rouby, PhD, Postdoctoral Fellow , Department of Pharmacotherapy and Translational Research, University of Florida: “Investigating the Utilization of Medications with Pharmacogenomics Evidence Support the Value of Preemptive Genotyping”

Fall 2017 – Spring 2018

June 15 – Lakshmi Manasa S Chekka, PharmD, Graduate Student, Department of Pharmacotherapy and Translational Research, University of Florida: “MicroRNAs as predictive biomarkers for antihypertensive response”
June 12 – Gillian Bell, PharmD, Clinical Pharmacist, Personalized Medicine Department – Mission Health, North Carolina: “Implementing Personalized Medicine in a Community Health System: The Mission Health Experience”
May 25 – Benjamin Duong, PharmD, Pharmacogenomics Resident, Department of Pharmacotherapy and Translational Research, University of Florida: “Clinical Implementation of a Pharmacogenetic Consult Service”
May 18 – Farran Weaver, PharmD, Resident, Department of Pharmacotherapy and Translational Research, University of Florida: “IV Diuretic Therapy for Heart Failure Patients in the Outpatient Setting”
May 4 – Kaylie Smith, PharmD, Ambulatory Care PGY-1 Resident, Department of Pharmacotherapy and Translational Research, University of Florida: “Outcomes of a Pharmacist-Monitored Direct Oral Anticoagulant Service in the Outpatient Setting”
April 27 – Amy Talana, PharmD, Ambulatory Care PGY-2 Resident, Department of Pharmacotherapy and Translational Research, University of Florida: “Patient-level Adherence and Interventions in a Pharmacist-led DOAC Clinic”
April 20 – Mohamed H. Shahin, PhD, Postdoctoral Associate, Department of Pharmacotherapy and Translational Research, University of Florida: “Finding a Needle in the Haystack by Integrating Multi-omics Data”
April 13 – Mariyem Naboulsi, PharmD & Trinity Williams, PharmD, MTM Residents, Department of Pharmacotherapy and Translational Research, University of Florida: “Motivational Interviewing for Pharmacists”
April 6 – Mohammad Alshaer PharmD & Abdelrahman Elsayed, PharmD, Graduate Students, Department of Pharmacotherapy and Translational Research, University of Florida: “MDR Tuberculosis: Ototoxicity of Aminoglycosides and Capreomycin” (Alshaer) & “Cytarabine Metabolic Pathway SNP Risk Score Predicts Leukemic Cell Intracellular Ara-CTP Levels in Pediatric AML Patients” (Elsayed)
March 30 – Awe Kwara, MB, ChB, Associate Professor of Medicine – Division of Infectious Diseases & Global Medicine, University of Florida: “Rifampin-containing anti-TB Therapy and NNRTIs Interactions”
March 16 – James Hoffman, PharmD, Chief Patient Safety Officer, St. Jude Children’s Research Hospital in Memphis, TN: “Accelerating the Implementation of Pharmacogenetics through Informatics and Standardization”
March 2 – Scott Garland, PharmD, Postdoctoral Fellow, Department of Pharmacotherapy and Translational Research, University of Florida: “Adverse Cardiovascular Event Risk Reduction in Type 2 Diabetes Mellitus with SGLT-2 inhibitors – an update on the literature”
February 23 – Hyunyoung Jeong, PharmD, PhD, Professor of Pharmacy Practice, University of Illinois at Chicago: “Genetic and Non-Genetic Factors Contributing to Inter Individual Variability in Drug Disposition”
February 9 – Kathleen Stringer, PharmD, Professor, College of Pharmacy, University of Michigan: “Metabolic Phenotyping of Sepsis and Sepsis Drug Response”
February 2 – Sonal Singh, PhD & Emily Schwartz, PharmD, Postdoctoral Associates, Department of Pharmacotherapy and Translational Research, University of Florida: “Targeted sequencing reveals novel misense variant in chromosome 12 locus associated with antihypertensive response to hydrochlorothiazide” (Singh) & “Implementation of Genotype-Guided Proton Pump Therapy in Children: A Pilot, Randomized, Multi-Site Pragmatic Trial” (Schwartz)
January 26 – D. Max Smith, PharmD & Scott Mosley, PharmD, Postdoctoral Fellows, Department of Pharmacotherapy and Translational Research, University of Florida: “Rationale, design, and impact of a pharmacogenetic service incorporating CYP2D6 genotype to guide opioid prescribing for cancer and non-cancer pain”
January 19 – Rhonda Cooper-DeHoff, Pharm.D., M.S., FAHA, FACC, Associate Professor, Department of Pharmacotherapy and Translational Research & Associate Director, Center for Pharmacogenomics, University of Florida: “2017 High Blood Pressure Guideline – What’s New, What’s Different?”
January 12 – Oyunbileg (Obiko) Magvanjav, Graduate Student, Department of Pharmacotherapy and Translational Research, University of Florida: “Genetic and Non-Genetic Correlates of Uncontrolled Blood Pressure on Combination Antihypertensive Therapy”
December 8 – Bradley Stockard, Pharm.D., Graduate Student, Department of Pharmacotherapy and Translational Research, University of Florida: “Metabolic Features Associated with Chemosensitivity in Pediatric AML Patients”
December 1 – Kristin Janke, Ph.D., Professor, Department of Pharmaceutical Care & Health Systems, University of Minnesota: “Committing to Student Leadership Development: Lessons from 10 Years in the Field as an Instructor”
November 17 – Martin Henman, BPharm, MA, Ph.D., MPSI, Associate Professor of Pharmacy, Trinity College Dublin: “Complexity of Medication Use in Ireland”
November 3 – Haojie Zhu, Ph.D., Assistant Professor of Pharmacy, Department of Clinical Pharmacy, University of Michigan: “Integration of a Novel Proteomics Approach into Pharmacogenomics Research”
October 27 – Wael Alghamdi, Pharm.D., Graduate Student, Department of Pharmacotherapy and Translational Research, University of Florida: “Treatment of MDR-TB: Focus on Two Novel Drugs”
September 29 – Adam Persky, Ph.D., Clinical Associate Professor, Co-Director of Quality Enhancement Plan, Division of Pharmacotherapy and Experimental Therapeutics, University of North Carolina: “Evidence Based Education: Implementation to Research”

Fall 2016 – Spring 2017

May 26 – Sarah Honaker, Pharm.D., PGY-1 Ambulatory Care Resident, University of Florida: “Effects of Atypical Antipsychotics on the Hemoglobin A1c”
May 19 – Sonal Singh, Ph.D., Postdoctoral Associate, Department of Pharmacotherapy and Translational Research, UF Center for Pharmacogenomics: “Friends or Foes: The duplicity of patient-specific IPSCs as a platform for Pharmacogenomics Research”
May 12 – Wen-Yi (Archie) Li, Graduate Student, Department of Pharmacotherapy and Translational Research, University of Florida: “Novel Therapeutic Targets in Non-Alcoholic Fatty Liver Disease”
May 5 – Kevin Cowart, Pharm.D., PGY-2 Ambulatory Care Resident, University of Florida: “Clinical Inertia in the Management of Diabetes Mellitus: Opportunities for the Pharmacist”
April 28 – Guang Yang, Graduate Student, Department of Pharmacotherapy and Translational Research, University of Florida: “Pharmacogenomics of Medication Related with Osteonecrosis of the Jaw”
April 21 – Amber Connelly, Pharm.D., Alexandre Endiakov, Pharm.D., Aditi Patel, Pharm.D., PGY-1 MTM Residents, University of Florida: “Quality Assessment of Medication Therapy Management Services”
April 14 – Gary Matzke, Pharm.D., FCCP, FCP, Professor, School of Pharmacy, Department of Pharmacotherapy and Outcomes Science, Virginia Commonwealth University: “Team-based Collaborative Pharmacy Practice Models: A Focus on the Improving Health of at Risk Rural Patients Pharmacist-Physician Collaborative Care Model”
March 31 – Adam Bress, Pharm.D., Research Assistant Professor, Department of Pharmacotherapy, University of Utah: “How do Pharmacoepidemiology and Pharmacogenetics Help Us Understand Health Disparities?”
March 24 – Max Smith, Pharm.D., BCPS, PGY-2 Pharmacogenetics Resident, College of Pharmacy, University of Florida: “An Update on Thiopurine S-methyltransferase (TPMT) Genotyping and Phenotyping at the University of Florida”
February 24 – Tim Spicer, Ph.D., Assistant Professor of Molecular Therapeutics, Scripps Research Institute: “A Scripps Florida and University of Florida Collaboration Aimed at Countering beta-lactam resistance in Pseudomonas aeruginosa”
February 10 – Laura Ramsey, Ph.D., Assistant Professor, Pharmacy Research, Division of Research in Patient Services, Cincinnati Children’s Hospital Medical Center: “Implementation of Pharmacogenetics at Cincinnati Children Hospital Medical Center: 12 Years of Successful Personalized Medicine”
February 3 – Orly Vardeny, Pharm.D., MS, FCCP, FAHA, BCACP, Associate Professor, School of Pharmacy & School of Medicine and Public Health, University of Wisconsin: “The INVESTED Trial: A One Shot deal to reduce CV Morbidity and Mortality”
January 27 – Dominick J. Angiolillo, MD, Ph.D., Professor of Medicine, Director of Cardiovascular Research, Program Director of Interventional Cardiology Fellowship, University of Florida College of Medicine – Jacksonville: “Antithrombotic Treatment for Patients with Atrial Fibrillation Undergoing PCI: North American Consensus Update”
January 20 – Andrew Hwang, Pharm.D., BCPS, Postdoctoral Fellow: “Direct Acting Oral Anticoagulants: Review of Clinical Monitoring”
January 13 – Jeffrey Bishop, Pharm.D., MS, BCPP, Associate Professor – Department of Experimental and Clinical Pharmacology, College of Pharmacy, University of Minnesota: “Pharmacogenomics studies of cognition and treatment response in psychotic disorder”
January 6 – J. Kevin Hicks, Pharm.D., Ph.D., Personalized Medicine Specialist – DeBartolo Family Personalized Medicine Institute at H. Lee Moffitt Cancer Center and Research Institute Tampa: “Integrating Precision Cancer Medicine into Patient Care”
October 28 – Scott Mosley, Pharm.D., Postdoctoral Fellow: “Precision medicine in cancer pain”
September 30 – Karen Sando, Pharm.D., BCACP, CDE, Clinical Assistant Professor: “Piloting Pharmacist-Led Medicare Annual Wellness Visits – Lessons Learned”

Fall 2015 – Spring 2016

May 12 – Nihal El Rouby, Pharm.D., Graduate Student: “The use of Genome Wide Association Analysis (GWAS) coupled with induced pluripotent stem cells (iPSC) to identify and validate genetic signals of resistant hypertension (RHTN)”
May 5 – Mohamed H. Shahin, Ph.D., Postdoctoral Fellow: “Integrating Pharmacometabolomics with Pharmacogenomics Reveals Novel Insights into Thiazide Diuretics Blood Pressure Response”
Apr. 28 – Kristin Rieser, Pharm.D., PGY-1 Resident: ” Evaluation of the appropriateness of target specific oral anticoagulant selection and monitoring in the outpatient setting”
Apr. 21 – Cynthia Moreau, Pharm.D., PGY-2 Ambulatory Care Resident: ” Electronic Cigarettes: All Smoke and Mirrors?”
Apr. 14 – Amy L. Seybert, Pharm.D., FASHP, FCCP, CHSE, Director – International Clinical Training Programs, Chair – Department of Pharmacy and Therapeutics, School of Pharmacy, University of Pittsburgh: “Simulation in Pharmacy Education: From Theory to Impact”
Apr. 7 – Ana Caroline Costa Sa, B.Pharm., MSc, Postdoctoral Fellow: “Molecular Markers of Blood Pressure Response to Thiazide Diuretics Identified Through Whole Transcriptome RNA-Seq Analysis”
Mar. 31 – Andrew Hwang, Pharm.D., BCPS, Postdoctoral Fellow: “Health-related Quality of Life Pertaining to Anticoagulation Therapy”
Mar. 24 – Dyson T. Wake, Pharm.D., PGY-2 Resident: “Value of Preemptive Pharmacogenetic Testing”
Mar. 17 – Steven M. Smith, Pharm.D., MPH, BCPS, Clinical Assistant Professor, Departments of Pharmacotherapy & Translational Research and Community Health & Family Medicine, Colleges of Pharmacy & Medicine: “Adverse Outcomes and Clinical Approaches to Resistant Hypertension”
Feb. 25 – Edith A. Nutescu, Pharm.D., M.S., FCCP, Associate Professor and Director, Center for Pharmacoepidemiology and Pharmacoeconomic Research, Department of Pharmacy Systems, Outcomes and Policy, College of Pharmacy, University of Illinois at Chicago: “Clinical Implementation of Warfarin Pharmacogenomics at University of Illinois Hospital and Health Sciences System”
Feb. 18 – Jessica V. Gonzalez, Pharm.D., C.Ph., Healthcare Quality & Medication Safety Fellow, UF College of Pharmacy: “99 Problems but Patient Safety Ain’t One”
Feb. 11 – Stephan Schmidt, Ph.D., Assistant Professor, Center for Pharmacometrics & Systems Pharmacology, Department of Pharmaceutics: “The application of quantitative clinical pharmacology tools in drug development and regulatory decision making: a value added proposition”
Feb. 4 – Leslie Hendeles, Pharm.D., Professor – Pharmacotherapy and Translational Research, Professor of Pediatrics (Pulmonary): “Determining Bioequivalence of Generic Inhalers for Asthma and COPD”
Jan. 14 – Christina L. Aquilante, Pharm.D., FCCP, Associate Professor, Department of Pharmaceutical Sciences, University of Colorado, Skaggs School of Pharmacy and Pharmaceutical Science: “Translational Research in Patients with Advanced Heart Failure”
Jan. 7 – Larisa H. Cavallari, Pharm.D., BCPS, FCCP, Associate Professor and Associate Chair, Director – Center for Pharmacogenomics, Associate Director – Personalized Medicine Program: “Potential for Individualized Heart Failure Therapy”
Dec. 10 – Charles Peloquin, Pharm.D., FCCP, Professor, Director – Infectious Disease Pharmacokinetics Lab: “Pole Vaulting with Rifamycins – How High Can You Go?”
Dec. 3 – Issam S. Hamadeh, Pharm.D., Postdoctoral Fellow: “Investigating the impact of the ultra-rapid metabolizer phenotype on Voriconazole exposure in patients with invasive fungal infections”
Nov. 19 – Marja Airaksinen, Ph.D., Professor of Social Pharmacy, University of Helsinki: “Medication Safety: A European Perspective”
Nov. 12 – Jason Karnes, Pharm.D., Ph.D., BCPS, Assistant Professor, University of Arizona College of Pharmacy: “Pharmacogenomics of heparin-induced thrombocytopenia: meeting the unmet clinical needs”
Nov. 5 – Lata Chauhan, Ph.D., Postdoctoral Associate: “Genome-wide Association Analysis Indentified Splicing SNP in CFLAR Predictive of Triptolid”
Oct. 29 – L. Michael Posey, CEO, Pharmacy Editorial & News Services, Inc. “Getting Published: Your Ticket to Fame & Fortune”
Oct. 22 – Alexander Vandell, Pharm.D., Ph.D., R.Ph., Associate Director, Clinical Pharmacogenomics, Daiichi Sankyo Pharma Development: “Pharmacogenomics in Industry: Focus on Edoxaban”
Oct. 15 – Sven Normann, Pharm.D., DABAT, Clinical Associate Professor; Carol Motycka, Pharm.D., BCACP, Clinical Associate Professor/Assistant Dean; Lindsey Childs-Kean, Pharm.D., MPH, BCPS, Clinical Assistant Professor; Randell Doty, Pharm.D., Clinical Associate Professor: “College’s Short Study Abroad”
Oct. 8 – Dominick Angiolillo, Ph.D., Professor of Medicine, Director – Cardiovascular Research, Program Director – Interventional Cardiology Fellowship, College of Medicine, UFL – Jacksonville: “Update on Antithrombotic Therapy in Acute Coronary Syndromes”
Oct. 1 – Roger B. Fillingim, Ph. D. Distinguished Professor – UF College of Dentistry , Director – UF Pain Research and Intervention Center of Excellence Clinical and Translational Research Building: “Individual Differences in Pain: Genetic and Non-Genetic Contributions”
Sept. 17 – Anne Snyder Franklin, Pharm.D., Clinical Assistant Professor: “Can TBL improve how we teach pharmacokinetics?”

Fall 2014 – Spring 2015

Aug. 28 – “Using Transcriptomics Metabolomics and Genomics“
Sept. 04 – “ Lessons Learned from NIH Childhood Asthma Research“
Sept. 18 – “ Got Snoring OSA in adults“
Oct. 2 – Kristine R. Crews, Pharm.D., BCPS, Translational Research Laboratory Director, Director, PGY2 Residency in Clinical Pharmacogenetics, Pharmaceutical Sciences Dept, St. Jude Children’s Research Hospital “Clinical Pharmacogenomics: Translating Research to Patient Care
Oct. 9 – Mervyn K. Kalman, BS Pharm, MBA, Associate Professor Emeritus, USC School of Pharmacy Medication Safety: Findings and Solutions, A Five Year Hospital Regulatory Review
Oct. 16 – Howard McLeod, Pharm.D., Medical Director, DeBartoloFamily Personalized Medicine Institute, Senior Member, Division of Population Sciences, Moffitt Cancer Center Cancer pharmacogenomics: team science is required
Oct. 23 – Liming Weng Meta-analysis of associations of glucose change in PEAR 1/2 subjects treated with B-blockers with genetic variations genotyped by Exome sequencing
Oct. 30 – Matt Hinton, Pharm.D., BCPS Clinical Pharmacy Specialist, Emergency Medicine Department of Pharmacy, Univ of Florida Health-Shands Martina Holder, Pharm.D., BCPS Emergency Medicine Pharmacy Specialist University of Florida Health-Shands The State of Pharmacy Practice in the Emergency Department
Nov. 6 – John S. Markowitz, Pharm.D., BCPP, PTR Carboxylesterase 1: Recent Developments in Pharmacogenomics
Nov. 13 – Richard F. Lockey, MD Distinguished Professor and Allergy Division Chief,Internal Medicine, University of South Florida, Anaphylaxis
Nov. 20 – Paul Doering, M.S. Emeritus Distinguished Service Professor, Dept of Pharmacotherapy & Translational Research, COP, UFL, Medical Marijuana
Dec. 4 – Andrea Gaedigk, PhD (Clinical Pharmacology, Toxicology & Therapeutic Innovation, Children’s Mercy Hospital, Kansas City) “CYP2D6 Pharmacogenetics: From Testing to Clinical Implementation”
Dec. 11 – Brian Isetts, PhD, BCPS, FAPhA Professor, Pharmaceutical Care & Health Systems, College of Pharmacy, University of Minnesota, “Pharmacists Responsibilities in Value-Based Healthcare Delivery & Financing“
Jan. 8 – Carl J. Pepine, MD, Professor, Division of Cardiovascular Medicine, University of Florida, “UF Cardiovascular Cell Therapy Program“
Jan. 15 – Tom Johns, Pharm.D., BCPS, Director of Pharmacy Services, UF Health Shands, Hospital, Clinical Associate Professor, COP, UFL, “UF Health Shands Hospital – Pharmacy Services“
Jan. 22 – Jacqueline King, Pharm.D., PGY-1 Pharmacy Practice Resident, Florida Hospital, Orlando via Video Conference from Orlando, “Management of HIT“
Jan. 29 – Israel Amirav, MD, Associate Professor, Pediatrics, Bar-Ilan University Ramat Gan, Israel, “Delivery of Inhaled Medications to Young Children“
Feb. 5 – Joy “Mika” Fujinaka, Pharm.D., PGY-1 Pharmacy Practice Resident, Florida Hospital, Orlando via VideoConference from Orlando, “Two is better than one: dual antiplatelet therapy in acute coronary syndrome“
Feb. 26 – Victoria Nazarov, Pharm.D. PGY – 1 Resident, UF MTM Communication and Care Center, Orlando, “MTM/Adherence Services“
Mar. 12 – Robert Green, Pharm.D., PGY-1 MTM/Geriatrics, Resident & Daryl Miller, Pharm.D., PGY-1, MTM/Geriatrics Resident, “Medication Therapy Management: Where are we headed?“
Mar. 19 – Cynthia Moreau, Pharm.D., PGY-1 Pharmacy Practice Resident, Florida Hospital, Celebration Health via VideoConference from Orlando, “The Pharmacist’s Role in Transitions of Care“
Mar. 26 – Leslie Hendeles, Pharm.D., Professor, College of Pharmacy and Professor of Pediatrics (Pulmonary), College of Medicine, “The controversy of Non-Prescription Bronchodilators for Asthma“
Apr. 2 – Abdullah Sultan, Pharm.D., Graduate Student, PTR, “Pharmacokineticd and Pharmacodynamics of Antituberculous Drugs using Routine Clinical Data“
Apr. 9 – Nihal El Rouby, Graduate Student, PTR, “Identification of Genetic Determinants of Resistant Hypertension RHTN through GWAS coupled“
Apr. 16 – Shirley Chang, Graduate Student, PTR, “Correlating the melatonin pathway with atenolol treatment-related glucose dysregulation through integrating genetic, metabolite, and fasting glucose data“
May 14 – Nicholas Carris, PharmD, BCPS, Post-doctoral Fellow, University of Florida Departments of Community Health & Family Medicine & PTR, “Fade Out“
May 21 – Hendrik Luesch, PhD, Assoc Professor of Medicinal Chemistry, Director, Center for Natural Products, Drug Discovery & Dev, “The Oceans as a Pharmacy“

Fall 2013 – Spring 2014

George L. Drusano, M.D. “Why Does Therapy Need to be Robust from the Start for Ventilator-requiring, Hospital-acquired Pneumonia”
Julie Johnson, Pharm.D. “UF Health Personalized Medicine Program (PMP)“
David Nelson, MD “Hepatitis C Treatment Paradigm: Evolving Role of Pharmacogenetics“
Randell E. Doty, Pharm.D. “History and Outcomes of the Alachua County FluMist Program“
Karen Sando, Pharm.D, CDE “The Pain and Promise of Electronic Health Records in Pharmacy Education“
Kathryn Blake, Pharm.D, BCPS, FCCP “Use of Mobile Devices and the Internet to Streamline an Asthma Clinical Trial“
Scott Gilbert, MD, MS “Clinical, Epdiemiological,and Genetic Perspectives on Prostate Cancer“
John Gums, Pharm.D., FCCP “Atrial Fibrillation: Update on Disease State and Therapeutic Options for the Prevention of Stroke“
Jamie R. Forrest, MS “Epidemiology of Asthma in Florida“
Bill Gurley, Ph.D. “Dietary Supplements and the Adolescent Athlete“
Issam Hamadeh, Pharm.D., BCPS, Post Doctoral Fellow “Impact of CYP2D6 Polymorphisms on the Clinical Efficacy and Tolerability of Immediate Release Metoprolol Tartrate“
Abdullah Sultan, Pharm.D., Ph.D. Grad Student “Population Pharmacokinetics of Antituberculous Drugs with a Focus on Pyrazinamide“
Ahmed Albassam, BS Pharm, Ph.D. Candidate “Green Tea: An Update on Drug Interactions and Potential Therapeutic Effects in Diabetes and Obesity“
Evan Hood, Pharm.D., Analisa Erhan, Pharm.D., PGY-1 MTM/Geriatrics Pharmacy Residents “Medication Therapy Management in Nontuberculous Mycobacterial Pulmonary Infections“
Shin-Wen Chang, Graduate Student “Blood Pressure Control: Not All Patients Are the Same“
Teri E. Klein, Ph.D.Pharmacogenomics Knowledge for Personalized Medicine
Ana Caroline Costa Sa, BPharm, MSc, Graduate Student “RNA-Seq: A Revolutionary Tool for Pharmacogenomics“
Nihal El Rouby, Pharm.D., BPharm “Resistant hypertension – A Review of Clinical Management, Non-Pharmacological Intervention and Preliminary Data on Genetic Association with Resistant Hypertension“
Marina Suzuki, Pharm.D., BCPS “Impact of Inflammatory Response on CYP-Mediated Interactions“
Tyler H. Gums, Pharm.D. “JNC-8: The Process, The Guidelines, & The Role of Clinical Pharmacy“
Peter O’Donnell, M.D. “Adoption of a Clinical Pharmacogenomics Implementation Program During Outpatient Care–The 1200 Patients Project“
Daren L. Knoell, Pharm.D., FACCP “Immunoregulatory Role of Zinc in the Host Response to Sepsis“
Nick Carris, Pharm.D., BCPS “Cystitis in the Post-Antiobiotic Era“
Ben Kong, Pharm.D., PGY-2 Pharmacogenetics Resident “Implementation of TPMT and Thiopurines into Clinical Practice: The Calm Before the Storm“
Patrick Cogan, Pharm.D., PGY-1 Pharmacy Resident “Evaluation of Pharmacy-Driven Medication Reconciliation Methods and Acceptance of Patient Care Recommendations“
Teresa Vo, Pharm.D., PGY-2 Pharmacogenetics Resident “One Size Fits One: Tailoring Pain Management to One’s Genetic Makeup“
Patti Haywood, Pharm.D. “Show Me the Money: Financially Sustainable Business Models for Ambulatory Care Pharmacy Services“
Jasneet Gandhi, Pharm.D., PGY-1 Pharmacy Resident and Alexander Miguel, Pharm.D. “Delivering comprehensive medication adherence intervention services driven by predictive analytic modeling for Medicare Advantage Prescription Drug plan members“
Mohamed Shahin, BPharm, M.Sc. “Using Multiple OMICs For The Identification Of Novel Biomarkers Of Blood Pressure Response To Antihypertensive Drugs”